Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/DF4D620D.svg?ark=w1%2F20260515%2FDF4D620D)](https://nobleid.org/work/w1/20260515/DF4D620D)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors